Executive Director Jonathan Agin recently traveled to Seattle, Washington from June 12-14th to attend the annual meeting of the Coalition Against Childhood Cancer, also known as CAC2. CAC2 began to
Executive Director Jonathan Agin Provides Public Comment Before the Food and Drug Administration On June 20, 2018, Executive Director Jonathan Agin provided open public comments before the Food and Drug
